Money
Snapchat Flourishes Since It Rebuffed Facebook's puny $3 billion offer
Hi, what are you looking for?
Jewish Business News
Business
Comparing Carl Icahn and Bill Ackman shows not all activist investing is created equal
Money
Rainbow's start-ups include Nano Retina, developing an artificial retina microchip that allows returning sight to the blind.
Business
Allergan's David Pyott had to fight Bill Ackman Day and Night to avoid a takeover by Valeant.
Money
Russian billionaires avoid oil tanking with investments in student housing.
Business
Teva says that the move is designed to reduce its finance costs.
Money
The partnership between Bronfman’s Claridge and Canadian company la Caisse will make investments of tens of millions of dollars in high-tech companies. Stephen Bronfman,...
Money
The former president and CEO Teva Americas Generics earned $7.3 million in 2014.
Money
Dan Loeb thinks the market in 2015 has been characterized by volatility
Business
David Tepper of Appaloosa management is taking a more activist stance than usual concerning GM's board.